Role of Endocannabinoid System in the Ventral Hippocampus of Rats in the Modulation of Anxiety‐Like Behaviours
Open Access
- 13 October 2009
- journal article
- research article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 105 (5) , 333-338
Abstract
Abstract: The effects of unilateral intra‐ventral hippocampus injection of URB597, a fatty acid amid hydrolase inhibitor, and AM251, a selective CB1receptor antagonist, on anxiety‐related behaviours using elevated plus‐maze test of anxiety were evaluated in the present study. Possible involvement of GABAergic system in those effects of URB597 was also evaluated. Injection of URB597 at the doses of 0.01, 0.1 and 1 μg/rat showed significant anxiogenic‐like effects at 0.1 and 1 μg/rat. However, intra‐ventral hippocampus injection of AM251 at the doses of 0.001, 0.01 and 0.1 μg/rat did not produce any significant effect in the elevated plus‐maze. The ineffective doses of selective GABAAreceptor antagonist, bicuculline (2 μg/rat) and selective GABABreceptor antagonist, phaclofen (1 μg/rat) on anxiety‐related behaviours were also injected with URB597 (0.1 μg/rat). The present data showed that neither bicuculline nor phaclofen affected the anxiogenic‐like effects of URB597. The results showed that injection of URB597 into the ventral hippocampus may be anxiogenic and GABAergic system may not be involved in its anxiogenic‐like effects.Keywords
This publication has 43 references indexed in Scilit:
- An endocannabinoid signaling system modulates anxiety-like behavior in male Syrian hamstersPsychopharmacology, 2008
- Interaction between cannabinoid compounds and diazepam on anxiety-like behaviour of micePharmacology Biochemistry and Behavior, 2008
- CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviourNeuropharmacology, 2008
- Correlated species differences in the effects of cannabinoid ligands on anxiety and on GABAergic and glutamatergic synaptic transmissionEuropean Journal of Neuroscience, 2007
- Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal grayNeuropharmacology, 2007
- ROLE OF DORSAL HIPPOCAMPAL CANNABINOID RECEPTORS AND NITRIC OXIDE IN ANXIETY LIKE BEHAVIOURS IN RATS USING THE ELEVATED PLUS‐MAZE TESTClinical and Experimental Pharmacology and Physiology, 2007
- P.4.b.001 Anxiolytic and reward-related properties of URB597, a novel FAAH inhibitor, in CD1 miceEuropean Neuropsychopharmacology, 2006
- Inhibition of Fatty-Acid Amide Hydrolase Accelerates Acquisition and Extinction Rates in a Spatial Memory TaskNeuropsychopharmacology, 2006
- Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanismsBritish Journal of Pharmacology, 2006
- The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxietyEuropean Journal of Neuroscience, 2002